• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplic

tetano

Editor, Senior Moderator
Front Immunol


. 2023 Mar 15;14:1107156.
doi: 10.3389/fimmu.2023.1107156. eCollection 2023.
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19


Anaïs Thiriard[SUP] 1 [/SUP], Benjamin Meyer[SUP] 2 [/SUP], Christiane S Eberhardt[SUP] 2 [/SUP], Natasha Loevy[SUP] 3 [/SUP], Serge Grazioli[SUP] 4 [/SUP], Wafae Adouan[SUP] 2 [/SUP], Paola Fontannaz[SUP] 2 [/SUP], Fabienne Marechal[SUP] 3 [/SUP], Arnaud G L'Huillier[SUP] 5 [/SUP], Claire-Anne Siegrist[SUP] 2 [/SUP], Daphnée Georges[SUP] 1 6 [/SUP], Antonella Putignano[SUP] 1 [/SUP], Arnaud Marchant[SUP] 1 [/SUP], Arnaud M Didierlaurent[SUP] 2 [/SUP], Geraldine Blanchard-Rohner[SUP] 2 7 [/SUP]



Affiliations

Abstract

Objectives: To comprehensively analyze the quality of the antibody response between children with Multisystem inflammatory syndrome (MIS-C) and age-matched controls at one month after SARS-CoV-2 exposure, and infected in the same time-period.
Methods: Serum from 20 MIS-C children at admission, and 14 control children were analyzed. Antigen specific antibody isotypes and subclasses directed against various antigens of SARS-CoV-2 as well as against human common coronavirus (HCoVs) and commensal or pathogenic microorganisms were assessed by a bead-based multiplexed serological assay and by ELISA. The functionality of these antibodies was also assessed using a plaque reduction neutralization test, a RBD-specific avidity assay, a complement deposition assay and an antibody-dependent neutrophil phagocytosis (ADNP) assay.
Results: Children with MIS-C developed a stronger IgA antibody response in comparison to children with uncomplicated COVID-19, while IgG and IgM responses are largely similar in both groups. We found a typical class-switched antibody profile with high level of IgG and IgA titers and a measurable low IgM due to relatively recent SARS-CoV-2 infection (one month). SARS-CoV-2-specific IgG antibodies of MIS-C children had higher functional properties (higher neutralization activity, avidity and complement binding) as compared to children with uncomplicated COVID-19. There was no difference in the response to common endemic coronaviruses between both groups. However, MIS-C children had a moderate increase against mucosal commensal and pathogenic strains, reflecting a potential association between a disruption of the mucosal barrier with the disease.
Conclusion: Even if it is still unclear why some children develop a MIS-C, we show here that MIS-C children produce higher titers of IgA antibodies, and IgG antibodies with higher functionality, which could reflect the local gastro-intestinal mucosal inflammation potentially induced by a sustained SARS-CoV-2 gut infection leading to continuous release of SARS-CoV-2 antigens.

Keywords: MIS-C multisystem inflammatory syndrome in children; SARS-CoV-2; antibody response; commensals; common coronavirus; functional antibody.
 
Back
Top Bottom